1. Home
  2. GNPX vs YAAS Comparison

GNPX vs YAAS Comparison

Compare GNPX & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.76

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$0.93

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
YAAS
Founded
2009
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
GNPX
YAAS
Price
$1.76
$0.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.5K
52.6K
Earning Date
05-11-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.06
52 Week High
$12.97
$7.00

Technical Indicators

Market Signals
Indicator
GNPX
YAAS
Relative Strength Index (RSI) 39.18 40.74
Support Level $0.18 $0.75
Resistance Level $2.12 $1.88
Average True Range (ATR) 0.10 0.08
MACD -0.01 0.02
Stochastic Oscillator 16.15 70.62

Price Performance

Historical Comparison
GNPX
YAAS

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: